Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

27.00
+0.30111.13%
Post-market: 27.000.00000.00%16:10 EDT
Volume:392
Turnover:10.60K
Market Cap:5.40M
PE:- -
High:27.00
Open:27.00
Low:27.00
Close:26.70
52wk High:27.94
52wk Low:22.63
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.61
T/O Rate:0.20%
Dividend:0.41
Dividend Rate:1.53%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Scholar Rock Holding Corporation - Pmda Agrees no Additional Clinical Studies Required; Scholar Rock to Submit Apitegromab Jnda by Ye 2026

THOMSON REUTERS
·
Aug 21

Scholar Rock Withdraws EU Apitegromab Filing After FDA Flags Catalent Indiana Plant with OAI Inspection Rating

Reuters
·
Aug 21

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

Hims & Hers Health (HIMS) Lifts Guidance As Scrutiny Builds, Is The Stock Fully Valued?

Simply Wall St.
·
Aug 21

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of USD 691,808 in Common Shares

Reuters
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21

Eli Lilly Revenue Jumps 48% as Mounjaro and Zepbound Sales Reach $14.9B

TradingKey
·
Aug 20

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

Barclays Sees Hims Sales Growth Amid Near-Term Profit Pressure

Reuters
·
Aug 20

Novonesis Expects Results from Weight-Loss Drug Supplement Study in 2027

Reuters
·
Aug 20

7 Growth Stocks Holding up in a Tough Market

Dow Jones
·
Aug 20

Will Foundayo’s UK GLP‑1 Approval and New R&D Deals Change Eli Lilly's (LLY) Narrative?

Simply Wall St.
·
Aug 20

Amplitude Therapeutics: Lilly to GET Exclusive, Target-Specific Rights to Develop ,Commercialize Licensed Products Directed to Collaboration Targets

THOMSON REUTERS
·
Aug 20

Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying Rna Vaccines for Infectious Diseases

THOMSON REUTERS
·
Aug 20

Amplitude: Initial Programs Target Infectious Diseases with High Unmet Need, with Lilly Retaining Options for up to Two Additional Targets

THOMSON REUTERS
·
Aug 20

World's Largest Companies by Market Cap (July 2026): Nvidia Leads, AI Theme Intact but Chip Stocks Face Valuation Adjustments

TradingKey
·
Aug 20

Moderately bullish activity in Novo Nordisk with shares up 1.32%

TIPRANKS
·
Aug 20

Viking Therapeutics (VKTX) Stock Still Looks Pricey With Pipeline Hopes Priced In

Simply Wall St.
·
Aug 20

Eli Lilly on Track for Record High Close

Dow Jones
·
Aug 20